- Home
- DWSN vs BDTX Comparison
DWSN vs BDTX Comparison
Compare DWSN & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DWSN | BDTX |
|---|---|---|
| Founded | 1952 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.3M | 116.8M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DWSN | BDTX |
|---|---|---|
| Price | $2.81 | $2.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 277.2K | ★ 545.1K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 53.85 | ★ 130.71 |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $145,773,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.08 | $1.31 |
| 52 Week High | $5.54 | $4.94 |
Technical Indicators
Market Signals| Indicator | DWSN | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.39 | 64.42 |
| Support Level | $1.64 | $2.45 |
| Resistance Level | $3.60 | $2.64 |
| Average True Range (ATR) | 0.48 | 0.14 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 50.16 | 94.31 |
Price Performance
Historical ComparisonAbout DWSN Dawson Geophysical Company
Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.